Versameb AG

Private

BaselHealthcare & Life Scienceshttps://versameb.com/

Last Round

VC Round

Jul 10, 2023

Total Funding Raised

$18.18M

Company Overview

Versameb AG is a biotechnology company that discovers and develops innovative RNA-based therapeutics for the modulation of protein expression and cellular targeting.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

mRNA therapeuticsRNA medicineRNA therapeuticsbiotechnologydrug discoverymRNA platformclinical-stage biotechtherapeutic targetsbiopharmaprotein expressiontissue regenerationRNA drug designprecision medicinebiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Versameb AG Comps

Public and private peers based on sector, stage, and business model.

Versameb AG comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Versameb AG Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Jul 10, 2023
Seed	Jul 15, 2020
Seed	Oct 17, 2019
Seed	Dec 18, 2018
Grant	Sep 18, 2017

View all Funding Rounds

Key People

Founding team and executive leadership

Klaas Zuideveld

Chief Executive Officer

Executive Team

Versameb AG Investors

Notable investors and investment history

Versameb AG investors
Investor	Rounds
BaseLaunch	Grant, VC Round, Seed

View all Investors

Versameb AG Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Versameb AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Versameb AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersBasel

Employee Range3

Year Founded2017

Last FundingJul 10, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.